Annual CFO
$183.43 M
-$90.34 M-33.00%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual cash flow from operations is $183.43 million, with the most recent change of -$90.34 million (-33.00%) on December 31, 2023.
- During the last 3 years, IRWD annual CFO has risen by +$14.59 million (+8.64%).
- IRWD annual CFO is now -33.00% below its all-time high of $273.76 million, reached on December 31, 2022.
Performance
IRWD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$9.88 M
-$23.58 M-70.46%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly cash flow from operations is $9.88 million, with the most recent change of -$23.58 million (-70.46%) on September 30, 2024.
- Over the past year, IRWD quarterly CFO has stayed the same.
- IRWD quarterly CFO is now -87.67% below its all-time high of $80.17 million, reached on March 31, 2023.
Performance
IRWD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$124.17 M
-$22.57 M-15.38%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM cash flow from operations is $124.17 million, with the most recent change of -$22.57 million (-15.38%) on September 30, 2024.
- Over the past year, IRWD TTM CFO has stayed the same.
- IRWD TTM CFO is now -57.16% below its all-time high of $289.81 million, reached on March 31, 2023.
Performance
IRWD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IRWD Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.0% | 0.0% | 0.0% |
| 3 y3 years | +8.6% | -84.7% | -52.6% |
| 5 y5 years | +358.8% | -84.7% | -52.6% |
IRWD Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.0% | at low | -87.7% | at low | -57.2% | at low |
| 5 y | 5-year | -33.0% | +1610.3% | -87.7% | at low | -57.2% | +1057.8% |
| alltime | all time | -33.0% | +167.1% | -87.7% | +110.6% | -57.2% | +145.4% |
Ironwood Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.88 M(-70.5%) | $124.17 M(-15.4%) |
| Jun 2024 | - | $33.47 M(-25.6%) | $146.74 M(-1.0%) |
| Mar 2024 | - | $44.98 M(+25.5%) | $148.24 M(-19.2%) |
| Dec 2023 | $183.43 M(-33.0%) | $35.83 M(+10.4%) | $183.43 M(-19.1%) |
| Sep 2023 | - | $32.46 M(-7.2%) | $226.78 M(-13.9%) |
| Jun 2023 | - | $34.96 M(-56.4%) | $263.41 M(-9.1%) |
| Mar 2023 | - | $80.17 M(+1.2%) | $289.81 M(+5.9%) |
| Dec 2022 | $273.76 M(+4.5%) | $79.18 M(+14.6%) | $273.76 M(+5.6%) |
| Sep 2022 | - | $69.09 M(+12.6%) | $259.15 M(-2.3%) |
| Jun 2022 | - | $61.37 M(-4.3%) | $265.12 M(+5.1%) |
| Mar 2022 | - | $64.12 M(-0.7%) | $252.32 M(-3.7%) |
| Dec 2021 | $261.89 M(+55.1%) | $64.57 M(-14.0%) | $261.89 M(+5.2%) |
| Sep 2021 | - | $75.06 M(+54.6%) | $248.84 M(+9.4%) |
| Jun 2021 | - | $48.57 M(-34.1%) | $227.41 M(+14.3%) |
| Mar 2021 | - | $73.69 M(+43.1%) | $198.93 M(+17.8%) |
| Dec 2020 | $168.84 M(+1474.2%) | $51.51 M(-4.0%) | $168.84 M(+16.5%) |
| Sep 2020 | - | $53.63 M(+167.0%) | $144.90 M(+15.0%) |
| Jun 2020 | - | $20.09 M(-53.9%) | $126.04 M(+30.3%) |
| Mar 2020 | - | $43.60 M(+58.1%) | $96.71 M(+801.8%) |
| Dec 2019 | $10.72 M(-115.1%) | $27.58 M(-20.7%) | $10.72 M(-241.5%) |
| Sep 2019 | - | $34.77 M(-476.4%) | -$7.58 M(-89.0%) |
| Jun 2019 | - | -$9.24 M(-78.2%) | -$68.93 M(-16.3%) |
| Mar 2019 | - | -$42.38 M(-557.1%) | -$82.38 M(+16.2%) |
| Dec 2018 | -$70.88 M(-29.6%) | $9.27 M(-134.9%) | -$70.88 M(-20.7%) |
| Sep 2018 | - | -$26.58 M(+17.1%) | -$89.37 M(-5.0%) |
| Jun 2018 | - | -$22.69 M(-26.5%) | -$94.03 M(-9.4%) |
| Mar 2018 | - | -$30.89 M(+235.2%) | -$103.79 M(+3.0%) |
| Dec 2017 | -$100.75 M(+288.5%) | -$9.21 M(-70.5%) | -$100.75 M(-9.0%) |
| Sep 2017 | - | -$31.24 M(-3.7%) | -$110.73 M(+38.2%) |
| Jun 2017 | - | -$32.45 M(+16.5%) | -$80.13 M(+48.5%) |
| Mar 2017 | - | -$27.85 M(+45.1%) | -$53.94 M(+108.0%) |
| Dec 2016 | -$25.93 M | -$19.19 M(+2874.7%) | -$25.93 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$645.00 K(-89.7%) | -$26.11 M(-49.5%) |
| Jun 2016 | - | -$6.26 M(-3990.1%) | -$51.69 M(-27.2%) |
| Mar 2016 | - | $161.00 K(-100.8%) | -$70.98 M(-33.6%) |
| Dec 2015 | -$106.93 M(-31.3%) | -$19.36 M(-26.2%) | -$106.93 M(-3.1%) |
| Sep 2015 | - | -$26.23 M(+2.6%) | -$110.35 M(-10.1%) |
| Jun 2015 | - | -$25.55 M(-28.6%) | -$122.80 M(-8.0%) |
| Mar 2015 | - | -$35.78 M(+57.1%) | -$133.46 M(-14.2%) |
| Dec 2014 | -$155.57 M(-43.1%) | -$22.78 M(-41.1%) | -$155.57 M(-11.0%) |
| Sep 2014 | - | -$38.68 M(+6.8%) | -$174.86 M(-9.9%) |
| Jun 2014 | - | -$36.21 M(-37.5%) | -$194.14 M(-18.5%) |
| Mar 2014 | - | -$57.89 M(+37.6%) | -$238.07 M(-12.9%) |
| Dec 2013 | -$273.36 M(+292.6%) | -$42.08 M(-27.4%) | -$273.36 M(+7.7%) |
| Sep 2013 | - | -$57.95 M(-27.7%) | -$253.74 M(+61.8%) |
| Jun 2013 | - | -$80.14 M(-14.0%) | -$156.79 M(+30.9%) |
| Mar 2013 | - | -$93.18 M(+314.9%) | -$119.75 M(+72.0%) |
| Dec 2012 | -$69.63 M(-7.4%) | -$22.46 M(-157.6%) | -$69.63 M(+26.9%) |
| Sep 2012 | - | $38.99 M(-190.5%) | -$54.88 M(-54.0%) |
| Jun 2012 | - | -$43.11 M(+0.1%) | -$119.28 M(+26.4%) |
| Mar 2012 | - | -$43.06 M(+459.2%) | -$94.39 M(+25.5%) |
| Dec 2011 | -$75.24 M(+10.8%) | -$7.70 M(-69.7%) | -$75.24 M(+10.3%) |
| Sep 2011 | - | -$25.41 M(+39.6%) | -$68.18 M(+4.0%) |
| Jun 2011 | - | -$18.21 M(-23.9%) | -$65.54 M(+0.5%) |
| Mar 2011 | - | -$23.91 M(+3601.7%) | -$65.20 M(-4.0%) |
| Dec 2010 | -$67.90 M(+1870.9%) | -$646.00 K(-97.2%) | -$67.90 M(+19.6%) |
| Sep 2010 | - | -$22.78 M(+27.5%) | -$56.78 M(+41.7%) |
| Jun 2010 | - | -$17.86 M(-32.9%) | -$40.08 M(+277.8%) |
| Mar 2010 | - | -$26.61 M(-354.2%) | -$10.61 M(+207.9%) |
| Dec 2009 | -$3.44 M(-87.8%) | $10.47 M(-272.5%) | -$3.44 M(-75.2%) |
| Sep 2009 | - | -$6.07 M(-152.3%) | -$13.91 M(+77.4%) |
| Jun 2009 | - | $11.60 M(-159.7%) | -$7.84 M(-59.7%) |
| Mar 2009 | - | -$19.45 M | -$19.45 M |
| Dec 2008 | -$28.20 M(+317.1%) | - | - |
| Dec 2007 | -$6.76 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual CFO year-on-year change?
- What is Ironwood Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly CFO year-on-year change?
- What is Ironwood Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM CFO year-on-year change?
What is Ironwood Pharmaceuticals annual cash flow from operations?
The current annual CFO of IRWD is $183.43 M
What is the all time high annual CFO for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual cash flow from operations is $273.76 M
What is Ironwood Pharmaceuticals annual CFO year-on-year change?
Over the past year, IRWD annual cash flow from operations has changed by -$90.34 M (-33.00%)
What is Ironwood Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of IRWD is $9.88 M
What is the all time high quarterly CFO for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly cash flow from operations is $80.17 M
What is Ironwood Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, IRWD quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of IRWD is $124.17 M
What is the all time high TTM CFO for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM cash flow from operations is $289.81 M
What is Ironwood Pharmaceuticals TTM CFO year-on-year change?
Over the past year, IRWD TTM cash flow from operations has changed by $0.00 (0.00%)